首 页
医药产品
医保药品
中标目录
医药招标
数据中心
医学资料
医药新闻
医药展会
OTC药品
保健品
医疗器械
处方药
专科药
中医药
器械中标目录
药品批发行情
求购信息
医药下载
药价简讯
当前位置:药药网 / 药品 / 美国NDC复合药物数据库文件(本栏目更新到2026-3-31)
药品名称:
商品名称:
药品NDC:
报告期内:
-
格式:2020-5-3
NDC包装id:
市场分类:
不限
ANDA
BLA
NDA
EMERGENCY USE AUTHORIZATION
NDA AUTHORIZED GENERIC
OTC MONOGRAPH FINAL
OTC MONOGRAPH NOT FINAL
UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
UNAPPROVED DRUG OTHER
UNAPPROVED HOMEOPATHIC
UNAPPROVED MEDICAL GAS
活性成分:
持证企业:
美国药品NDC(国家药品编码)与药品说明书数据库
美国NDC未完成药物数据库文件
美国NDC复合药物数据库文件
美国NDC 数据库排除药物数据库文件
 美国NDC复合药物数据库文件4843条(本栏目更新到2026-3-31)
药品名称(分析)
商品名
药品NDC
专利人(分析)
报告期内
活性成分
市场分类
规格(分析)
NDC包装id
071023 ECONAZOLE NITRATE 1% / NIACINAMIDE 4%
HUMAN COMPOUNDED DRUG
72934-2358
SKNV
2024-1
ECONAZOLE NITRATE; NIACINAMIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
1 g/100 mL; 4 g/100 mL
72934-2358-2
011500 DAPSONE 6% / NIACINAMIDE 4% Gel
HUMAN COMPOUNDED DRUG
72934-1321
SKNV
2024-1
NIACINAMIDE; DAPSONE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
4 g/100 mL; 6 g/100 mL
72934-1321-2
Fentanyl Citrate 50mcg/mL in 50mL Cassette
HUMAN COMPOUNDED DRUG
73013-1001
OurPharma LLC
2023-2
FENTANYL CITRATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
50 ug/1 mL
73013-1001-1
testosterone cypionate inj.
HUMAN COMPOUNDED DRUG
57377-200
Advanced Pharmaceutical Technology, Inc.
2024-2
TESTOSTERONE CYPIONATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
200 mg/1 mL
57377-200-00
Fentanyl Citrate 50mcg/mL (2,500mcg Total Dose) 50mL IV Syringe
HUMAN COMPOUNDED DRUG
71170-910
Apollo Care, LLC
2024-2
FENTANYL CITRATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.05 mg/1 mL
71170-910-25
Fentanyl Citrate 50mcg/mL (2,500mcg Total Dose) 50mL IV Bag
HUMAN COMPOUNDED DRUG
71170-900
Apollo Care, LLC
2024-2
FENTANYL CITRATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.05 mg/1 mL
71170-900-01
Vancomycin 750mg added to 250mL of 0.9% Sodium Chloride
HUMAN COMPOUNDED DRUG
71170-244
Apollo Care, LLC
2024-2
VANCOMYCIN HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
3 mg/1 mL
71170-244-25
Vancomycin 1g added to 250mL of 0.9% Sodium Chloride
HUMAN COMPOUNDED DRUG
71170-254
Apollo Care, LLC
2024-2
VANCOMYCIN HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
4 mg/1 mL
71170-254-25
Vancomycin 1.25g added to 250mL of 0.9% Sodium Chloride
HUMAN COMPOUNDED DRUG
71170-264
Apollo Care, LLC
2024-2
VANCOMYCIN HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
5 mg/1 mL
71170-264-25
Vancomycin 1.75g added to 500mL of 0.9% Sodium Chloride
HUMAN COMPOUNDED DRUG
71170-194
Apollo Care, LLC
2024-2
VANCOMYCIN HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
3.5 mg/1 mL
71170-194-50
ESTRADIOL 10MG
HUMAN COMPOUNDED DRUG
73693-373
FARMAKEIO OUTSOURCING LLC
2024-2
ESTRADIOL
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
10 mg
73693-373-01
TESTOSTERONE 100 MG
HUMAN COMPOUNDED DRUG
73693-384
FARMAKEIO OUTSOURCING LLC
2024-2
TESTOSTERONE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
100 mg
73693-384-01
TESTOSTERONE, TRIAMCINOLONE 37.5MG, 7.5MCG
HUMAN COMPOUNDED DRUG
73693-380
FARMAKEIO OUTSOURCING LLC
2024-2
TESTOSTERONE; TRIAMCINOLONE ACETONIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
37.5 mg; 7.5 ug
73693-380-01
ESTRADIOL 20MG
HUMAN COMPOUNDED DRUG
73693-376
FARMAKEIO OUTSOURCING LLC
2024-2
ESTRADIOL
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
20 mg
73693-376-01
TESTOSTERONE, TRIAMCINOLONE 25MG, 5MCG
HUMAN COMPOUNDED DRUG
73693-379
FARMAKEIO OUTSOURCING LLC
2024-2
TRIAMCINOLONE ACETONIDE; TESTOSTERONE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
5 ug; 25 mg
73693-379-01
TESTOSTERONE 200 MG
HUMAN COMPOUNDED DRUG
73693-381
FARMAKEIO OUTSOURCING LLC
2024-2
TESTOSTERONE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
200 mg
73693-381-01
TESTOSTERONE, TRIAMCINOLONE 200MG, 40MCG
HUMAN COMPOUNDED DRUG
73693-364
FARMAKEIO OUTSOURCING LLC
2024-2
TRIAMCINOLONE ACETONIDE; TESTOSTERONE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
40 ug; 200 mg
73693-364-01
ESTRADIOL 12.5MG
HUMAN COMPOUNDED DRUG
73693-377
FARMAKEIO OUTSOURCING LLC
2024-2
ESTRADIOL
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
12.5 mg
73693-377-01
Trophamine 3% / Dextrose 5% With Calcium Gluconate 3.75mEq and Heparin 125 units 250ml in 250ml bag
HUMAN COMPOUNDED DRUG
72196-0419
Central Admixture Pharmacy Services, Inc.
2024-2
GLUTAMIC ACID; LYSINE ACETATE; SERINE; TYROSINE; N-ACETYLTYROSINE; THREONINE; CYSTEINE HYDROCHLORIDE; HISTIDINE; ARGININE; TAURINE; DEXTROSE MONOHYDRATE; LEUCINE; METHIONINE; PROLINE; ASPARTIC ACID; ISOLEUCINE; ALANINE; GLYCINE; PHENYLALANINE; TRYPTOPHAN; VALINE; CALCIUM GLUCONATE MONOHYDRATE; HEPARIN SODIUM
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.375 g/250 mL; .9 g/250 mL; .285 g/250 mL; .033 g/250 mL; .18 g/250 mL; .315 g/250 mL; .018 g/250 mL; .36 g/250 mL; .9 g/250 mL; .01875 g/250 mL; 12.5 g/250 mL; 1.05 g/250 mL; .255 g/250 mL; .51 g/250 mL; .24 g/250 mL; .615 g/250 mL; .405 g/250 mL; .27 g/250 mL; .36 g/250 mL; .15 g/250 mL; .585 g/250 mL; 3.75 meq/250 mL; 125 U/250 mL
72196-0419-1
Trophamine 2.5%/Dextrose 10% With Calcium Gluconate 3.75mEq and Heparin 125 units 250ml in 250ml bag
HUMAN COMPOUNDED DRUG
71285-0418
Central Admixture Pharmacy Services, Inc.
2024-2
CALCIUM GLUCONATE MONOHYDRATE; GLUTAMIC ACID; LYSINE ACETATE; SERINE; TYROSINE; N-ACETYLTYROSINE; THREONINE; CYSTEINE HYDROCHLORIDE; HISTIDINE; ARGININE; TAURINE; DEXTROSE MONOHYDRATE; LEUCINE; METHIONINE; PROLINE; ASPARTIC ACID; ISOLEUCINE; ALANINE; GLYCINE; PHENYLALANINE; TRYPTOPHAN; VALINE; HEPARIN SODIUM
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
3.75 meq/250 mL; .3125 g/250 mL; .75 g/250 mL; .2375 g/250 mL; .0275 g/250 mL; .15 g/250 mL; .2625 g/250 mL; .015 g/250 mL; .3 g/250 mL; .75 g/250 mL; .01563 g/250 mL; 25 g/250 mL; .875 g/250 mL; .2125 g/250 mL; .425 g/250 mL; .2 g/250 mL; .5125 g/250 mL; .3375 g/250 mL; .225 g/250 mL; .3 g/250 mL; .125 g/250 mL; .4875 g/250 mL; 125 U/250 mL
71285-0418-1
首页
(current)
39
(current)
40
(current)
41
(current)
42
(current)
43
(current)
44
(current)
45
(current)
46
(current)
47
(current)
48
(current)
(current)
末页
(current)
网站地图
-
网站开发
-
网站简介
-
会员服务
-
法律声明
-
联系我们
-
药品招商频道
-
药品信息排行
-
2018年版国家基本药物目录
-
意见反馈
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:
医药研究数据
|
医药资料
|
SDA药品评审中心
|
中医网
|
中药处方系统
|
爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究 客服热线:0575-83552251 / 13754370441 QQ客服:
浙ICP备16010490号-2
增值电信业务经营许可证:
浙B2-20220931
互联网药品信息服务资格证书编号:
(浙)-经营性2023-0215
浙公网安备:330683240604819103159
医药代理商群1:
医药代理商群2:
医药代理商群3: